Cathay Biotech Past Earnings Performance
Past criteria checks 1/6
Cathay Biotech's earnings have been declining at an average annual rate of -2%, while the Chemicals industry saw earnings growing at 7.9% annually. Revenues have been growing at an average rate of 4.8% per year. Cathay Biotech's return on equity is 3%, and it has net margins of 18.1%.
Key information
-2.0%
Earnings growth rate
-5.0%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 4.8% |
| Return on equity | 3.0% |
| Net Margin | 18.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
There Are Reasons To Feel Uneasy About Cathay Biotech's (SHSE:688065) Returns On Capital
Jun 19
Cathay Biotech (SHSE:688065) Has A Somewhat Strained Balance Sheet
May 28What Cathay Biotech Inc.'s (SHSE:688065) 27% Share Price Gain Is Not Telling You
May 07We Think That There Are More Issues For Cathay Biotech (SHSE:688065) Than Just Sluggish Earnings
May 06Revenue & Expenses Breakdown
How Cathay Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,293 | 414 | 198 | 184 |
| 31 Dec 23 | 2,114 | 367 | 215 | 189 |
| 30 Sep 23 | 2,169 | 381 | 235 | 179 |
| 30 Jun 23 | 2,183 | 459 | 256 | 187 |
| 31 Mar 23 | 2,285 | 436 | 270 | 199 |
| 31 Dec 22 | 2,441 | 553 | 239 | 188 |
| 30 Sep 22 | 2,447 | 605 | 207 | 184 |
| 30 Jun 22 | 2,517 | 619 | 188 | 164 |
| 31 Mar 22 | 2,538 | 628 | 182 | 145 |
| 31 Dec 21 | 2,363 | 595 | 181 | 134 |
| 30 Sep 21 | 2,099 | 612 | 143 | 118 |
| 30 Jun 21 | 1,839 | 564 | 147 | 99 |
| 31 Mar 21 | 1,579 | 481 | 144 | 97 |
| 31 Dec 20 | 1,497 | 458 | 146 | 84 |
| 30 Sep 20 | 1,482 | 428 | 181 | 70 |
| 30 Jun 20 | 1,601 | 432 | 203 | 41 |
| 31 Mar 20 | 1,722 | 475 | 258 | 105 |
| 31 Dec 19 | 1,916 | 479 | 212 | 90 |
| 31 Dec 18 | 1,757 | 466 | 185 | 86 |
| 31 Dec 17 | 1,363 | 333 | 131 | 65 |
| 31 Dec 16 | 929 | 145 | 105 | 38 |
Quality Earnings: 688065 has high quality earnings.
Growing Profit Margin: 688065's current net profit margins (18.1%) are lower than last year (19.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688065's earnings have declined by 2% per year over the past 5 years.
Accelerating Growth: 688065's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688065 had negative earnings growth (-5%) over the past year, making it difficult to compare to the Chemicals industry average (-16.4%).
Return on Equity
High ROE: 688065's Return on Equity (3%) is considered low.